Press Releases


Date Title
2020-08-04Aug 04, 2020 9 Meters Biopharma, Inc. to Participate in August Investor Conferences www.demo.9meters.com/pressnews
2020-07-28Jul 28, 2020 9 Meters Biopharma, Inc. Announces Issuance of Patent for Use of Larazotide in Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) www.demo.9meters.com/pressnews
2020-07-21Jul 21, 2020 9 Meters Biopharma, Inc. Doses the First Patients in Phase 1b/2a Clinical Trial in Short Bowel Syndrome www.demo.9meters.com/pressnews
2020-07-06Jul 06, 2020 9 Meters Biopharma, Inc. Appoints Michael T. Constantino to Board of Directors www.demo.9meters.com/pressnews
2020-07-02Jul 02, 2020 9 Meters Biopharma, Inc. to Participate in BMO Capital Markets' "Hidden Gems in Healthcare Conference Call Series" www.demo.9meters.com/pressnews
2020-06-29Jun 29, 2020 9 Meters Biopharma, Inc. Amends Definition of Primary Endpoint for Phase 3 Trial in Celiac Disease After Consultation with FDA www.demo.9meters.com/pressnews
2020-06-24Jun 24, 2020 9 Meters Biopharma, Inc. Initiates Phase 1b/2a Clinical Trial in Short Bowel Syndrome www.demo.9meters.com/pressnews
2020-05-11May 11, 2020 9 Meters Biopharma, Inc Receives Thorough QT Study Waiver by FDA for Larazotide Being Studied for Celiac Disease www.demo.9meters.com/pressnews
2020-05-07May 07, 2020 9 Meters Biopharma, Inc Announces the Closing of Naia Rare Diseases Acquisition www.demo.9meters.com/pressnews
2020-05-05May 05, 2020 9 Meters Biopharma Hosting Research and Development Day www.demo.9meters.com/pressnews
2020-05-04May 04, 2020 9 Meters Biopharma, Inc Announces the Closing of $22.5 Million Private Placement Funding www.demo.9meters.com/pressnews
2020-04-30Apr 30, 2020 9 Meters Biopharma, a Rare, Orphan and Unmet Needs GI-Focused Company, is Created with the Transformative Merger Between Innovate Biopharmaceuticals and RDD Pharma www.demo.9meters.com/pressnews
2020-03-20Mar 20, 2020 Innovate Biopharmaceuticals Announces Full Year 2019 Financial Results And Strategic And Operational Updates www.demo.9meters.com/pressnews
2020-03-11Mar 11, 2020 Innovate Biopharmaceuticals Affirms Timeline for Closing of Merger with RDD Pharma Ltd. Closing Expected Around the End of the First Quarter of 2020 www.demo.9meters.com/pressnews
2020-02-19Feb 19, 2020 Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts for the 2020 Digestive Disease Week (DDW) Conference www.demo.9meters.com/pressnews
2020-02-18Feb 18, 2020 Innovate Biopharmaceuticals Announces Shareholder Approval of All Proposals in Connection with the Pending Merger with RDD Pharma Ltd. to Create 9 Meters Biopharma, a GI-focused Platform Company www.demo.9meters.com/pressnews
2019-10-07Oct 07, 2019 Innovate Biopharmaceuticals to Merge with RDD Pharma Creating New Gastroenterology Company Focused on Specialty, Rare and Orphan Diseases www.demo.9meters.com/pressnews
2019-08-13Aug 13, 2019 Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac Disease www.demo.9meters.com/pressnews
2019-08-08Aug 08, 2019 Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates www.demo.9meters.com/pressnews
2019-07-15Jul 15, 2019 Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings Release www.demo.9meters.com/pressnews
2019-06-24Jun 24, 2019 Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer www.demo.9meters.com/pressnews
2019-06-10Jun 10, 2019 Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac Disease www.demo.9meters.com/pressnews
2019-05-20May 20, 2019 Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Larazotide at the 2019 Digestive Disease Week Conference in San Diego www.demo.9meters.com/pressnews
2019-05-09May 09, 2019 Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego www.demo.9meters.com/pressnews
2019-05-01May 01, 2019 Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering www.demo.9meters.com/pressnews
2019-04-29Apr 29, 2019 Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-Market www.demo.9meters.com/pressnews
2019-04-29Apr 29, 2019 Innovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action of Re-normalizing the Intestinal Barrier, to Demonstrate Improvements in validated NASH Biomarkers and Endpoints in synergy with obeticholic acid, an FXR ag www.demo.9meters.com/pressnews
2019-04-26Apr 26, 2019 Innovate Biopharmaceuticals First Quarter 2019 Financial Results and Operational Progress Updates - Webcast Details www.demo.9meters.com/pressnews
2019-04-11Apr 11, 2019 Innovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver (EASL) Demonstrating Positive Effect of Larazotide on Reduced Intestinal Permeability in a NASH Preclinical Study www.demo.9meters.com/pressnews
2019-04-02Apr 02, 2019 Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on April 29, 2019 www.demo.9meters.com/pressnews
2019-03-26Mar 26, 2019 Innovate Biopharmaceuticals Announces Collaboration with Institut Gustave Roussy to Study Regulation of Intestinal Permeability and the Gut Microbiota using Larazotide in Immuno-oncology Checkpoint Inhibitor Failure Pre-Clinical Models www.demo.9meters.com/pressnews
2019-03-19Mar 19, 2019 Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate Highlights www.demo.9meters.com/pressnews
2019-03-18Mar 18, 2019 Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 19, 2019 www.demo.9meters.com/pressnews
2019-03-18Mar 18, 2019 Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial www.demo.9meters.com/pressnews
2019-03-13Mar 13, 2019 Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 18, 2019 www.demo.9meters.com/pressnews
2019-03-06Mar 06, 2019 Innovate Biopharmaceuticals Announces Presentation at Cowen’s 39th Annual Health Care Conference in Boston www.demo.9meters.com/pressnews
2019-03-01Mar 01, 2019 Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019 www.demo.9meters.com/pressnews
2019-02-26Feb 26, 2019 Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates www.demo.9meters.com/pressnews
2019-02-25Feb 25, 2019 Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference www.demo.9meters.com/pressnews
2019-02-22Feb 22, 2019 Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer www.demo.9meters.com/pressnews
2019-02-07Feb 07, 2019 Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference www.demo.9meters.com/pressnews
2018-12-17Dec 17, 2018 Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-line NASH Data with Drug Combinations by EASL 2019 www.demo.9meters.com/pressnews
2018-12-04Dec 04, 2018 Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital and Announces Capital Update for the Celiac Disease Clinical Program and its NASH Development Strategy on December 17, 2018 www.demo.9meters.com/pressnews
2018-11-26Nov 26, 2018 Innovate Biopharmaceuticals Strengthens Clinical Development with the Addition of Patrick H. Griffin, M.D., F.A.C.P. www.demo.9meters.com/pressnews
2018-11-13Nov 13, 2018 Innovate Biopharmaceuticals Reports Third Quarter 2018 Earnings and Key Corporate Highlights www.demo.9meters.com/pressnews
2018-11-12Nov 12, 2018 Sanyal Biotechnology and Innovate Biopharmaceuticals Present Data at AASLD Validating a Proprietary “Leaky Gut” Assay Demonstrating Reduced Intestinal Permeability with Larazotide Acetate Treatment in a NASH Preclinical Study www.demo.9meters.com/pressnews
2018-11-05Nov 05, 2018 Innovate Biopharmaceuticals Announces Presentation at the BIO-Europe Conference, Copenhagen 2018 - 24th Annual Partnering Conference www.demo.9meters.com/pressnews
2018-10-31Oct 31, 2018 Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference www.demo.9meters.com/pressnews
2018-10-29Oct 29, 2018 Innovate Biopharmaceuticals Announces Positive Effect of Larazotide Acetate on Reducing Intestinal Permeability in a NASH Preclinical Study www.demo.9meters.com/pressnews
2018-10-01Oct 01, 2018 Innovate Biopharmaceuticals Announces Participation at the Ladenburg Thalmann 2018 Healthcare Conference www.demo.9meters.com/pressnews
2018-09-06Sep 06, 2018 Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City. www.demo.9meters.com/pressnews
2018-08-31Aug 31, 2018 Innovate Biopharmaceuticals Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City September 4-6, 2018 www.demo.9meters.com/pressnews
2018-08-23Aug 23, 2018 Innovate Biopharmaceuticals Enters into an Agreement with Amarex Clinical Research for Data Management and Biostatistics for Phase 3 Celiac Disease Trial www.demo.9meters.com/pressnews
2018-08-15Aug 15, 2018 Innovate Biopharmaceuticals Reports Second Quarter 2018 Earnings and Key Corporate Highlights www.demo.9meters.com/pressnews
2018-08-03Aug 03, 2018 Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City www.demo.9meters.com/pressnews
2018-07-31Jul 31, 2018 Innovate Biopharmaceuticals Enters into a Collaboration on Larazotide’s Effect on Improving the Microbiome of Children with EED with the University of Virginia School of Medicine www.demo.9meters.com/pressnews
2018-06-28Jun 28, 2018 Innovate Biopharmaceuticals Enters into an R&D Collaboration on Larazotide’s Corrective Effect on the Dysfunctional Intestinal Barrier and the Dysfunctional Microbiome in various Diseases with the University of Maryland School of Medicine www.demo.9meters.com/pressnews
2018-06-25Jun 25, 2018 Innovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® Indexes www.demo.9meters.com/pressnews
2018-06-13Jun 13, 2018 Innovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna Kazanchyan, M.D. www.demo.9meters.com/pressnews
2018-05-31May 31, 2018 Innovate Biopharmaceuticals Scheduled to Present at the Jefferies Global Healthcare Conference in New York on Friday, June 8, 2018, at 11:30AM www.demo.9meters.com/pressnews
2018-05-22May 22, 2018 Innovate Biopharmaceuticals Scheduled to Present at BIO 2018 Convention in Boston on Tuesday, June 5, 2018, at 4:45PM www.demo.9meters.com/pressnews
2018-05-17May 17, 2018 Celiac Disease KOL and Management Meetings around the Digestive Disease Week (DDW) conference on Monday, June 4, 2018, in Washington, D.C. www.demo.9meters.com/pressnews
2018-05-16May 16, 2018 Innovate Biopharmaceuticals Reports First Quarter 2018 Key Financial and Corporate Highlights www.demo.9meters.com/pressnews
2018-05-09May 09, 2018 Innovate Biopharmaceuticals Announces Acceptance of Two Abstracts for the Digestive Disease Week 2018 Conference www.demo.9meters.com/pressnews
2018-04-05Apr 05, 2018 Innovate Biopharmaceuticals, Inc. to Present at the H.C. Wainwright Annual Global Life Sciences Conference on April 9, 2018 www.demo.9meters.com/pressnews
2018-03-13Mar 13, 2018 Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer www.demo.9meters.com/pressnews
2018-03-07Mar 07, 2018 Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at the Cowen Healthcare Conference on March 13, 2018, Tuesday at 8:40 AM ET www.demo.9meters.com/pressnews
2018-02-07Feb 07, 2018 Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at BIO CEO & Investor Conference on Monday, February 12, 2018 at 3:30PM ET www.demo.9meters.com/pressnews
2018-01-31Jan 31, 2018 Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018 www.demo.9meters.com/pressnews
2018-01-30Jan 30, 2018 Innovate Biopharmaceuticals Announces Successful Merger Completion www.demo.9meters.com/pressnews
2017-12-28Dec 28, 2017 Innovate Biopharmaceuticals' Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability www.demo.9meters.com/pressnews
2017-09-06Sep 06, 2017 Innovate Biopharma’s Pediatric Ulcerative Colitis Drug Granted FDA Orphan Designation www.demo.9meters.com/pressnews
2017-07-12Jul 12, 2017 Innovate Biopharmaceuticals Submits Orphan Drug Application to FDA for Pediatric Ulcerative Colitis Indication www.demo.9meters.com/pressnews
2017-07-03Jul 03, 2017 Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreement www.demo.9meters.com/pressnews
2017-06-19Jun 19, 2017 Monster Digital and Innovate Biopharmaceuticals Enter into Letter of Intent regarding Reverse Merger www.demo.9meters.com/pressnews
2017-06-06Jun 06, 2017 Innovate Biopharmaceuticals to present progress towards phase 3 celiac disease trials at BIO 2017 Convention www.demo.9meters.com/pressnews
2017-02-21Feb 21, 2017 Innovate Biopharmaceuticals to Highlight its Late-Stage Product Pipeline Targeting Celiac Disease and Ulcerative Colitis at The Cowen Healthcare Conference on March 6, 2017 www.demo.9meters.com/pressnews
2017-01-04Jan 04, 2017 Innovate Biopharmaceuticals Targeting Celias disease and Ulcerative Colitis, Meeting With Potentional Investors, Partners During J.P. Morgan Healthcare Confernce www.demo.9meters.com/pressnews
2016-05-18May 18, 2016 Innovate Biopharmaceuticals, Inc. will be Attending the 2016 Piper Jaffray Healthcare Conference Meeting in San Diego from Friday, May 20 - 23, 2016 www.demo.9meters.com/pressnews
2016-02-29Feb 29, 2016 Innovate Biopharmaceuticals Completes License for Late-Stage Celiac Disease Asset from Alba Therapeutics www.demo.9meters.com/pressnews
2016-02-25Feb 25, 2016 Innovate Biopharmaceuticals, Inc. Presenting at Cowen Healthcare Conference Monday, March 7, 2016, and at Future Leaders in the Biotech Industry Friday, March 11, 2016 www.demo.9meters.com/pressnews
2016-02-25Feb 25, 2016 Innovate Biopharmaceuticals, Targeting Celiac Disease and Ulcerative Colitis, to Present at the Piper Jaffray Healthcare Conference in New York on Tuesday, Nov. 29 www.demo.9meters.com/pressnews
2015-01-05Jan 05, 2015 Innovate Biopharmaceuticals Acquires Late - Stage Pancreatic Imaging Assets www.demo.9meters.com/pressnews

Email Alerts     Print Page

Data may be delayed up to 15 minutes